Isoquercitrin suppresses colon cancer cell growth in vitro by targeting the Wnt/β-Catenin signaling pathway

Journal of Biological Chemistry

Volumn 289, Issue 51, 2014, Pages 35456-35457

  Amado, Nathália G ^a   Predes, Danilo ^a   Fonseca, Barbara F ^a   Cerqueira, Débora M ^a   Reis, Alice H ^a   Dudenhoeffer, Ana C ^a   Borges, Helena L ^a   Mendes, Fábio A ^a   Abreu, Jose G ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; DISEASES; FLAVONOIDS; SIGNALING; TUMORS;

ANTI-INFLAMMATORIES; BIOLOGICAL EFFECTS; CANONICAL WNT SIGNALING; CATENIN SIGNALING; COLON CANCER CELLS; EMBRYONIC DEVELOPMENT; INHIBITORY EFFECT; SIGNALING PATHWAYS;

CELL SIGNALING;

BETA CATENIN; ISOQUERCITRIN; WNT PROTEIN; ANTINEOPLASTIC AGENT; EARLY GROWTH RESPONSE FACTOR 2; LITHIUM CHLORIDE; QUERCETIN; XENOPUS PROTEIN;

ADULT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CELL GROWTH; COLON CANCER; CONTROLLED STUDY; DRUG SPECIFICITY; DRUG TARGETING; EMBRYO; EMBRYO PATTERN FORMATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SIGNAL TRANSDUCTION; XENOPUS; ACTIVE TRANSPORT; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; CELL MOTION; CELL NUCLEUS; CELL PROLIFERATION; COLON TUMOR; DRUG EFFECTS; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; MORPHOGENESIS; NONMAMMALIAN EMBRYO; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTINEOPLASTIC AGENTS; BETA CATENIN; BLOTTING, WESTERN; BODY PATTERNING; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; COLONIC NEOPLASMS; EARLY GROWTH RESPONSE PROTEIN 2; EMBRYO, NONMAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LITHIUM CHLORIDE; QUERCETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WNT SIGNALING PATHWAY; XENOPUS; XENOPUS PROTEINS;

EID: 84919344117     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.621599     Document Type: Article

References (40)

1. Sies, H. (2010) Polyphenols and health: update and perspectives. Arch. Biochem. Biophys. 501, 2-5
2. Sarkar, F. H., Li, Y., Wang, Z., and Kong, D. (2009) Cellular signaling perturbation by natural products. Cell. Signal. 21, 1541-1547
3. Amado, N. G., Fonseca, B. F., Cerqueira, D. M., Neto, V. M., and Abreu, J. G. (2011) Flavonoids: potential Wnt/β-catenin signaling modulators in cancer. Life Sci. 89, 545-554
4. McMahon, A. P., and Moon, R. T. (1989) Ectopic expression of the protooncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis. Cell 58, 1075-1084
5. Niehrs, C. (2010) On growth and form: a Cartesian coordinate system of Wnt and BMP signaling specifies bilaterian body axes. Development 137, 845-857
6. Zhang, X., Abreu, J. G., Yokota, C., MacDonald, B. T., Singh, S., Coburn, K. L. A., Cheong, S.-M., Zhang, M. M., Ye, Q.-Z., Hang, H. C., Steen, H., and He, X. (2012) Tiki1 is required for head formation via Wnt cleavageoxidation and inactivation. Cell 149, 1565-1577
7. Kim, S.-E., Huang, H., Zhao, M., Zhang, X., Zhang, A., Semonov, M. V., MacDonald, B. T., Zhang, X., Garcia Abreu, J., Peng, L., and He, X. (2013) Wnt stabilization of β-catenin reveals principles for morphogen receptorscaffold assemblies. Science 340, 867-870
8. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., and Clevers, H. (1996) XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 86, 391-399
9. Logan, C. Y., and Nusse, R. (2004) The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810
10. Clevers, H. (2006) Wnt/β-Catenin signaling in development and disease. Cell 127, 469-480
11. Tarapore, R. S., Siddiqui, I. A., and Mukhtar, H. (2012) Modulation of Wnt/β-catenin signaling pathway by bioactive food components. Carcinogenesis 33, 483-491
12. Manach, C., Scalbert, A., Morand, C., Rémésy, C., and Jiménez, L. (2004) Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79, 727-747
13. Hallett, R. M., Kondratyev, M. K., Giacomelli, A. O., Nixon, A. M., Girgis-Gabardo, A., Ilieva, D., and Hassell, J. A. (2012) Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer. PloS One 7, e33976
14. Lee, J., Lee, J., Jung, E., Hwang, W., Kim, Y.-S., and Park, D. (2010) Isorhamnetin-induced anti-adipogenesis is mediated by stabilization of β-catenin protein. Life Sci. 86, 416-423
15. Amado, N. G., Fonseca, B. F., Cerqueira, D. M., Reis, A. H., Simas, A. B., Kuster, R. M., Mendes, F. A., and Abreu, J. G. (2012) Effects of natural compounds on Xenopus embryogenesis: a potential read out for functional drug discovery targeting Wnt/β-catenin signaling. Curr. Top. Med. Chem. 12, 2103-2113
16. Amado, N. G., Cerqueira, D. M., Menezes, F. S., da Silva, J. F., Neto, V. M., and Abreu, J. G. (2009) Isoquercitrin isolated from Hyptis fasciculata reduces glioblastoma cell proliferation and changes β-catenin cellular localization. Anticancer Drugs 20, 543-552
17. Nieuwkoop, P. D., and Faber, J. (eds) (1956) Normal Table of Xenopus laevis (Daudin): A Systematical and Chronological Survey of the Development from the Fertilized Egg till the End of Metamorphosis, p. 22, Garland Publishing, London
18. Reis, A. H., Almeida-Coburn, K. L., Louza, M. P., Cerqueira, D. M., Aguiar, D. P., Silva-Cardoso, L., Mendes, F. A., Andrade, L. R., Einicker-Lamas, M., and Atella, G. C. (2012) Plasma membrane cholesterol depletion disrupts prechordal plate and affects early forebrain patterning. Dev. Biol. 365, 350-362
19. Abreu, J. G., Ketpura, N. I., Reversade, B., and De Robertis, E. (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat. Cell Biol. 4, 599-604
20. Reversade, B., and De Robertis, E. (2005) Regulation ofADMPand BMP2/ 4/7 at opposite embryonic poles generates a self-regulating morphogenetic field. Cell 123, 1147-1160
21. Kao, K. R., Masui, Y., and Elinson, R. P. (1986) Lithium-induced respecification of pattern in Xenopus laevis embryos. Nature 322, 371-373
22. Garcia-Abreu, J., Moura Neto, V., Carvalho, S. L., and Cavalcante, L. A. (1995) Regionally specific properties of midbrain glia: I. Interactions with midbrain neurons. J. Neurosci. Res. 40, 471-477
23. Brannon, M., Gomperts, M., Sumoy, L., Moon, R. T., and Kimelman, D. (1997) A β-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus. Genes Dev. 11, 2359-2370
24. Haramoto, Y., Takahashi, S., and Asashima, M. (2007) Monomeric mature protein of Nodal-related 3 activates Xbra expression. Dev. Genes Evol. 217, 29-37
25. Huang, P., Senga, T., and Hamaguchi, M. (2007) A novel role of phos-pho-β-catenin in microtubule regrowth at centrosome. Oncogene 26, 4357-4371
26. Aoki, M., Hecht, A., Kruse, U., Kemler, R., and Vogt, P. K. (1999) Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. Proc. Natl. Acad. Sci. U.S.A. 96, 139-144
27. Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., Sprick, M. R., Kemper, K., Richel, D. J., Stassi, G., and Medema, J. P. (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nature Cell Biol. 12, 468-476
28. Dajas, F. (2012) Life or death: neuroprotective and anticancer effects of quercetin. J. Ethnopharmacol. 143, 383-396
29. Tetsu, O., and McCormick, F. (1999) β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426 Isoquercitrin Inhibits Wnt/β-Catenin Signaling
30. De Sousa E Melo, F., Wang, X., Jansen, M., Fessler, E., Trinh, A., de Rooij, L. P. M. H., de Jong, J. H., de Boer, O. J., van Leersum, R., Bijlsma, M. F., and Rodermond, H., van der Heijden, M., van Noesel, C. J., Tuynman, J. B., Dekker, E., Markowetz, F., Medema, J. P., and Vermeulen, L. (2013) Poorprognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat. Med. 19, 614-618
31. Markowitz, S. D., and Bertagnolli, M. M. (2009) Molecular basis of colorectal cancer. New Engl. J. Med. 361, 2449-2460
32. Russo, G. L. (2007) Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem. Pharmacol. 74, 533-544
33. Boots, A. W., Li, H., Schins, R. P., Duffin, R., Heemskerk, J. W., Bast, A., and Haenen, G. R. (2007) The quercetin paradox. Toxicol. Applied Pharmacol. 222, 89-96
34. Park, C. H., Chang, J. Y., Hahm, E. R., Park, S., Kim, H.-K., and Yang, C. H. (2005) Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells. Biochem. Biophys. Res. Comm. 328, 227-234
35. Nijveldt, R. J., van Nood, E., van Hoorn, D. E., Boelens, P. G., van Norren, K., and van Leeuwen, P. A. (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74, 418-425
36. Pietta, P.-G. (2000) Flavonoids as antioxidants. J. Nat. Prod. 63, 1035-1042
37. Tapiero, H., Tew, K. D., Ba, G. N., and Mathé, G. (2002) Polyphenols: do they play a role in the prevention of human pathologies? Biomed. Pharmacother. 56, 200-207
38. Cialdella-Kam, L., Nieman, D. C., Sha, W., Meaney, M. P., Knab, A. M., and Shanely, R. A. (2013) Dose-response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults. Br. J. Nutr. 109, 1923-1933
39. Ferry, D. R., Smith, A., Malkhandi, J., Fyfe, D. W., deTakats, P. G., Anderson, D., Baker, J., and Kerr, D. J. (1996) Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2, 659-668
40. Okamoto, T. (2005) Safety of quercetin for clinical application (Review). Int. J. Mol. Med. 16, 275-278